Oyster Point Pharma Inc (OYST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OYST | AMGN | BMY | VRTX | GILD |
| Company | Oyster Point Pharma Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 11.16 | 268.92 | 55.84 | 423.41 | 92.26 |
| High | 11.20 | 270.31 | 56.42 | 424.58 | 93.07 |
| Low | 11.12 | 267.15 | 55.08 | 415.15 | 90.82 |
| Last | 11.17 | 269.43 | 56.38 | 416.96 | 91.65 |
| Change | +0.02 | +0.49 | +0.47 | -7.30 | -0.73 |
| % Change | +0.18% | +0.18% | +0.84% | -1.72% | -0.79% |
| Volume | 2,088,200 | 2,684,500 | 9,060,900 | 1,226,000 | 8,955,300 |
| 20-Day Average Volume | 306,230 | 3,582,535 | 10,988,220 | 2,074,325 | 6,584,240 |
| Previous Close | 11.15 | 268.94 | 55.91 | 424.26 | 92.38 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.13 | 263.34 | 56.75 | 412.86 | 91.83 |
| 20-Day Raw Stochastic | 76.47% | 82.64% | 42.03% | 40.60% | 51.51% |
| 20-Day Relative Strength | 66.58% | 45.84% | 49.16% | 43.40% | 51.41% |
| Weighted Alpha | -44.20 | -15.51 | +17.85 | -8.82 | +15.02 |
| Today's Opinion | 100% Buy | 88% Sell | 40% Buy | 72% Sell | 40% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 40% Buy | 72% Sell | 88% Buy |
| Last Month's Opinion | 100% Buy | 88% Sell | 80% Buy | 24% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 12/22/22 | +1.98% since 01/08/25 | -0.76% since 01/08/25 | +1.18% since 01/08/25 | +2.82% since 01/08/25 |
| Low | 11.04 on 12/23/22 | 260.55 on 01/10/25 | 54.81 on 01/13/25 | 397.24 on 01/13/25 | 88.57 on 01/10/25 |
| High | 11.20 on 12/30/22 | 272.82 on 01/15/25 | 56.74 on 01/15/25 | 425.49 on 01/15/25 | 93.07 on 01/16/25 |
| 1-Month | |||||
| %Chg | -0.09% since 11/30/22 | +1.10% since 12/16/24 | +0.91% since 12/16/24 | -10.92% since 12/16/24 | -0.43% since 12/16/24 |
| Low | 11.04 on 12/23/22 | 253.30 on 12/19/24 | 54.81 on 01/13/25 | 377.85 on 12/19/24 | 88.57 on 01/10/25 |
| High | 11.25 on 12/01/22 | 272.82 on 01/15/25 | 58.54 on 12/18/24 | 474.18 on 12/17/24 | 94.55 on 12/26/24 |
| 3-Month | |||||
| %Chg | +98.75% since 09/30/22 | -16.23% since 10/16/24 | +5.64% since 10/16/24 | -14.43% since 10/16/24 | +5.65% since 10/16/24 |
| Low | 5.17 on 10/03/22 | 253.30 on 12/19/24 | 51.81 on 10/28/24 | 377.85 on 12/19/24 | 85.60 on 10/22/24 |
| High | 11.83 on 11/07/22 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +157.97% since 06/30/22 | -19.12% since 07/16/24 | +36.84% since 07/16/24 | -14.73% since 07/16/24 | +27.93% since 07/16/24 |
| Low | 4.20 on 07/07/22 | 253.30 on 12/19/24 | 41.20 on 07/17/24 | 377.85 on 12/19/24 | 70.78 on 07/23/24 |
| High | 11.83 on 11/07/22 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 299,847 | 144,564,128 | 113,395,376 | 109,259,248 | 115,130,048 |
| Shares Outstanding, K | 26,844 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 24,540,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -100,660,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 5,590,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -36,750,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.35 | 0.56 | 0.45 | 0.40 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.37 on 11/10/22 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 02/23/23 | 02/04/25 | 02/06/25 | 02/03/25 | 02/11/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.620 on 01/03/25 | N/A | 0.770 on 12/13/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.90 | 47.64 | 0.00 | 20.54 |